Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dose of intrathecal hyperbaric bupivacaine for repeated spinal anesthesia in cesarean section
TCTR20250218003Not yet recruiting
- Sponsor
- Faculty of Medicine, Prince of Songkhla University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of bupivacaine in None, sponsored by Faculty of Medicine, Prince of Songkhla University. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
bupivacaine
Beyond the preview
Go deeper on TCTR20250218003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250218003.